Growth Metrics

Fortress Biotech (FBIO) Income towards Parent Company: 2009-2024

Historic Income towards Parent Company for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to -$120.9 million.

  • Fortress Biotech's Income towards Parent Company rose 133.03% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.2 million, marking a year-over-year increase of 36.67%. This contributed to the annual value of -$120.9 million for FY2024, which is 21.60% up from last year.
  • Per Fortress Biotech's latest filing, its Income towards Parent Company stood at -$120.9 million for FY2024, which was up 21.60% from -$154.2 million recorded in FY2023.
  • Fortress Biotech's Income towards Parent Company's 5-year high stood at -$103.0 million during FY2020, with a 5-year trough of -$213.9 million in FY2022.
  • Over the past 3 years, Fortress Biotech's median Income towards Parent Company value was -$154.2 million (recorded in 2023), while the average stood at -$163.0 million.
  • Per our database at Business Quant, Fortress Biotech's Income towards Parent Company slumped by 60.07% in 2021 and then climbed by 27.94% in 2023.
  • Over the past 5 years, Fortress Biotech's Income towards Parent Company (Yearly) stood at -$103.0 million in 2020, then crashed by 60.07% to -$164.9 million in 2021, then dropped by 29.76% to -$213.9 million in 2022, then rose by 27.94% to -$154.2 million in 2023, then increased by 21.60% to -$120.9 million in 2024.